Vizora日本語

PeptiDream×Kidswell Bio

Different ways of making money, on the same scale.

Same yardstick

MetricPeptiDreamFY ending Dec 2024Kidswell BioFY ending Mar 2026
Revenue¥46.7B¥6.59B
COGS ratio26.1%73.5%
Operating margin45.2%-2.1%
Net margin32.2%-6.3%
FCF margin46.3%-16.9%

Highlighted = best value for that metric

Compare industry percentiles by axis

Each row uses the same 0–100 scale. Dots show each company's rank within its primary industry.

  • PeptiDreamPrimary industry: Biotech & Regenerative Medicine
  • Kidswell BioPrimary industry: Biotech & Regenerative Medicine
CompanyRank

  • Revenue growth

    • PeptiDreamN/A
    • Kidswell BioN/A

  • Profitability

    • PeptiDream91.76 peers
    • Kidswell Bio256 peers

  • Cash conversion

    • PeptiDream62.54 peers
    • Kidswell BioN/A

  • Efficiency

    • PeptiDream64.37 peers
    • Kidswell Bio92.97 peers

  • Financial strength

    • PeptiDreamN/A
    • Kidswell BioN/A

Each dot is a company's percentile within its primary industry; peer groups may differ. Missing axes are labeled as unavailable. No combined score is calculated, and industry rank is not an investment recommendation.

Money flows side by side

Chart height is proportional to revenue.

PeptiDream¥46.7B · keeps ¥45 per ¥100
Kidswell Bio¥6.59B · keeps ¥-2 per ¥100

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open Markdown